Edwards Lifesciences Corp [EW] stock prices are down -4.96% to $69.36 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EW shares have lost -2.19% over the last week, with a monthly amount drifted -3.40%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on January 30, 2025, when Stifel upgraded its rating to a Buy and also boosted its price target to $90 from $75. Previously, Wolfe Research downgraded its rating to Underperform on January 16, 2025, and kept the price target unchanged to $60. On December 16, 2024, upgrade upgraded it’s rating to Buy. Jefferies downgraded its rating to a Hold and reduced its price target to $70 on September 18, 2024. Daiwa Securities upgraded its rating to Outperform for this stock on July 31, 2024. In a note dated July 29, 2024, Wolfe Research upgraded an Peer Perform rating on this stock.
The stock price of Edwards Lifesciences Corp [EW] has been fluctuating between $58.93 and $95.25 over the past year. Currently, Wall Street analysts expect the stock to reach $76.56 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $69.36 at the most recent close of the market. An investor can expect a potential return of 10.38% based on the average EW price forecast.
Analyzing the EW fundamentals
The Edwards Lifesciences Corp [NYSE:EW] reported sales of 5.72B for trailing twelve months, representing a drop of -9.67%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.73%. To continue investigating profitability, this company’s Return on Assets is posted at 0.32, Equity is 0.49 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 68.22 points at the first support level, and at 67.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.11, and for the 2nd resistance point, it is at 72.86.
Ratios To Look Out For
It’s worth pointing out that Edwards Lifesciences Corp [NYSE:EW]’s Current Ratio is 4.18. Also, the Quick Ratio is 3.45, while the Cash Ratio stands at 2.02. Considering the valuation of this stock, the price to sales ratio is 7.10, the price to book ratio is 4.08 and price to earnings (TTM) ratio is 28.32.
Transactions by insiders
Recent insider trading involved Ullem Scott B., CVP, Chief Financial Officer, that happened on Mar 26 ’25 when 11250.0 shares were sold. Officer, Ullem Scott B. completed a deal on Mar 26 ’25 to buy 22500.0 shares. Meanwhile, CVP,Strategy/Corp Development BOBO DONALD E JR sold 9500.0 shares on Mar 13 ’25.
